A novel series of macrocyclic inhibitors of norovirus 3CL protease inhibitors is reported. High resolution crystal structures of enzyme-inhibitor complexes have confirmed the mechanism of action. The structural determinants involved in binding have been delineated. The inhibitor design rationale was validated by x-ray crystallographic studies.